Leptin deficiency is uniquely treated with recombinant human metreleptin, while those with LEPR, PCSK1, or POMC deficiency can now be treated with the MC4R agonist setmelanotide. This evidence concerns the gene PCSK1 and hyperinsulinemic hypoglycemia, familial, 4.